Auteurs
Merge
Accueil
Racine
Merge
Exploration
Accueil
Racine
Accueil
Racine

Serveur d'exploration Tocilizumab - Merge (Accueil)

Index « Auteurs » - entrée « E. N. Alexandrova »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
E. Márquez-Fernández < E. N. Alexandrova < E. Naderi  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
002A45 (2013) A. Novikov ; E. N. Alexandrova ; A. N. Gerasimov [Russie] ; A. S. Avdeeva ; G. V. Lukina ; Y. A. Sigidin ; T. V. Popkova ; E. Y. Panasyuk ; E. L. NasonovTHU0122 Multi-Biomarker Scores as Predictors of Response to Biologic Therapies in Rheumatoid Arthritis
003167 (2013) A. S. Avdeeva ; E. N. Alexandrova ; E. Y. Panasyuk ; G. V. Lukina ; E. L. Nasonov [Russie]AB0509 Comparative effectiveness of tocilizumab (TCZ) and rituximab (RTM) using different disease activity indices (DAS 28, SDAI and CDAI) in patients with rheumatoid arthritis (RA)
003243 (2013) E. V. Udachkina [Russie] ; D. S. Novikova [Russie] ; T. V. Popkova [Russie] ; A. S. Avdeeva [Russie] ; A. A. Novikov [Russie] ; E. N. Alexandrova [Russie] ; A. V. Volkov [Russie] ; E. L. Nasonov [Russie]AB0306 Tocilizumab therapy resulted in significantly increased heart rate variability and improved lipid profile in patients with rheumatoid arthritis
003252 (2013) A. S. Avdeeva [Russie] ; E. N. Alexandrova [Russie] ; A. V. Smirnov [Russie] ; A. A. Novikov [Russie] ; M. V. Cherkasova [Russie] ; E. Y. Panasyuk [Russie] ; E. L. Nasonov [Russie]AB0299 Association of basal level antibodies to modified citrullinated vimentin (anti-mcv) with joint destruction in rheumatoid arthritis (ra) patients during the tocilizumab (tcz) therapy
003281 (2013) A. S. Avdeeva ; E. N. Alexandrova ; A. A. Novikov ; E. Y. Panasyuk ; M. V. Cherkasova ; E. L. Nasonov [Russie]AB0259 The high basal level antibodies to modified citrullinated vimentin (anti-MCV) – predictive factor of response to tocilizumab therapy in rheumatoid arthritis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Merge

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "E. N. Alexandrova" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "E. N. Alexandrova" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    E. N. Alexandrova
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021